US Stock MarketDetailed Quotes

BTAI BioXcel Therapeutics

Watchlist
  • 2.210
  • -0.100-4.33%
Trading Feb 18 09:44 ET
6.85MMarket Cap-0.07P/E (TTM)

BioXcel Therapeutics Key Stats

BioXcel Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 350.000K--
--2024/Q4-- / 718.260K--
Nov 14, 20242024/Q3214.000K / 1.328M--
Aug 6, 20242024/Q21.104M / 1.100M--
May 9, 20242024/Q1582.000K / 632.600K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 350.000K--
--2024/Q4-- / 718.260K--
Nov 14, 20242024/Q3214.000K / 1.328M--
Aug 6, 20242024/Q21.104M / 1.100M--
May 9, 20242024/Q1582.000K / 632.600K--

Unlock Free Earnings Estimates

BioXcel Therapeutics Earnings Reports

Read more

Trending Stocks

Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More